FAM200A Antibody (Z-9): sc-81867

FAM200A Antibody (Z-9) is a mouse monoclonal IgM antibody that detects FAM200A protein of human origin by western blotting (WB), immunoprecipitation (IP), and enzyme-linked immunosorbent assay (ELISA). Anti-FAM200A antibody (Z-9) is available as the non-conjugated form. FAM200A plays a crucial role in cellular signaling pathways, particularly in the regulation of cell proliferation and differentiation, which are essential processes for maintaining tissue homeostasis and responding to injury. Dysregulation of FAM200A has been implicated in various diseases, including cancer, where altered expression can contribute to tumor progression and metastasis. Understanding FAM200A function is vital for developing targeted therapies and improving treatment outcomes for patients with conditions linked to dysfunction. Additionally, chromosome 7, which harbors the FAM200A gene, is associated with several genetic disorders, highlighting the importance of studying FAM200A in the context of both normal physiology and disease.

Alexa Fluor^® is a trademark of Molecular Probes Inc., OR., USA

LI-COR^® and Odyssey^® are registered trademarks of LI-COR Biosciences

FAM200A Antibody (Z-9) References:

1. The DNA sequence of human chromosome 7.  |  Hillier, LW., et al. 2003. Nature. 424: 157-64. PMID: 12853948
2. The neurobiology of Williams syndrome: cascading influences of visual system impairment?  |  Eckert, MA., et al. 2006. Cell Mol Life Sci. 63: 1867-75. PMID: 16810457
3. Shwachman-Diamond syndrome.  |  Shimamura, A. 2006. Semin Hematol. 43: 178-88. PMID: 16822460
4. Williams-Beuren syndrome diagnosis using fluorescence in situ hybridization.  |  Osborne, LR., et al. 2006. Methods Mol Med. 126: 113-28. PMID: 16930009
5. Lissencephaly 1 linking to multiple diseases: mental retardation, neurodegeneration, schizophrenia, male sterility, and more.  |  Reiner, O., et al. 2006. Neuromolecular Med. 8: 547-65. PMID: 17028375
6. Structural aberrations of chromosome 7 revealed by a combination of molecular cytogenetic techniques in myeloid malignancies.  |  Brezinová, J., et al. 2007. Cancer Genet Cytogenet. 173: 10-6. PMID: 17284364
7. Therapy-related leukemia and myelodysplasia: susceptibility and incidence.  |  Leone, G., et al. 2007. Haematologica. 92: 1389-98. PMID: 17768113
8. Restriction fragment length polymorphism associated with the pro alpha 2(I) gene of human type I procollagen. Application to a family with an autosomal dominant form of osteogenesis imperfecta.  |  Tsipouras, P., et al. 1983. J Clin Invest. 72: 1262-7. PMID: 6313757
9. Molecular anatomy of chromosome 7q deletions in myeloid neoplasms: evidence for multiple critical loci.  |  Liang, H., et al. 1998. Proc Natl Acad Sci U S A. 95: 3781-5. PMID: 9520444